# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-050202
Filing Date
2021-04-14
Accepted
2021-04-14 16:08:43
Documents
4
Period of Report
2021-05-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm212463-1_def14a.htm | DEF 14A | 617355
2 | GRAPHIC | lg_protagonist-pn.jpg | GRAPHIC | 35831
3 | GRAPHIC | tm212463d1-proxy_protapg1bw.jpg | GRAPHIC | 489062
4 | GRAPHIC | tm212463d1-proxy_protapg2bw.jpg | GRAPHIC | 374143
| Complete submission text file | 0001104659-21-050202.txt |  | 1856038

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37852 | Film No.: 21825804
SIC: 2834 Pharmaceutical Preparations